ARCHIVES

In Congress: Time Running out On Effort To Double Market Exclusivity Term

This article is from The Cancer Letter archive.

Vol. 23 No. 43 | November 7, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Oncology Unit Fastest in Approvals Despite Having Highest Workload

May 9, 2014

NCI programs: AIDS Malignancy Program gets new director, authority.

November 4, 2005

RFA On Natural Inhibitors Role In Prevention Released

April 2, 1982

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014

FDA orders “limited distribution” for lung cancer drug Iressa.

June 24, 2005

Administration’s FY 1981 Budget Would Leave Gaps, Curtail Many Program, Without New Cuts

March 28, 1980